Trial intelligence / Profile preview

Tetraspan vs Albumin for Volume Replacement in Cardiac Surgery

NCT01418521Phase 4Unknown

Sponsor
Rambam Health Care Campus
Start
Aug 2011
Primary completion
Jul 2013
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 4 trial of hydroxyethyl starch 130/0.42 in hypovolemia, sponsored by Rambam Health Care Campus. Status: unknown.

02

Drugs

hydroxyethyl starch 130/0.42
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT01418521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01418521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call